Novo Nordisk keeps growing, fuelling hopes of a stock rebound
Novo Nordisk reported 18% sales growth in the first half of 2025, despite a profit warning that triggered a record share drop. Goldman Sachs says the sell-off is overdone and analysts highlight a potential buying opportunity.
https://anessoft.com/blog/ar/macron-evoque-une-possible-reprise-du-dialogue-avec-vladimir-poutine
Novo Nordisk reported 18% sales growth in the first half of 2025, despite a profit warning that triggered a record share drop. Goldman Sachs says the sell-off is overdone and analysts highlight a potential buying opportunity.
What's Your Reaction?
